Impact of nutritional status on the prognosis of patients with metastatic hormone-naïve prostate cancer: a multicenter retrospective cohort study in Japan

Pretreatment serum albumin/globulin ratio as a prognostic biomarker in metastatic prostate cancer patients treated with maximal androgen blockade

(2018) Le-Ye He et al.   ASIAN JOURNAL OF ANDROLOGY

Obese patients with castration-resistant prostate cancer may be at a lower risk of all-cause mortality: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database

(2018) Adriana C. Vidal et al.   BJU INTERNATIONAL

Current treatment strategies for advanced prostate cancer

(2017) Kazumasa Komura et al.   INTERNATIONAL JOURNAL OF UROLOGY

Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer

(2017) Karim Fizazi et al.   NEW ENGLAND JOURNAL OF MEDICINE

The Geriatric Nutritional Risk Index Predicts Survival in Elderly Esophageal Squamous Cell Carcinoma Patients with Radiotherapy

(2016) Yacong Bo et al.   PLoS One

Cancer statistics, 2015

(2015) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer

(2015) Christopher J. Sweeney et al.   NEW ENGLAND JOURNAL OF MEDICINE

Nutritional screening is strongly associated with overall survival in patients treated with targeted agents for metastatic renal cell carcinoma

(2015) Weijie Gu et al.   Journal of Cachexia Sarcopenia and Muscle

The role of inflammation, iron, and nutritional status in cancer-related anemia: results of a large, prospective, observational study

(2014) A. Maccio et al.   HAEMATOLOGICA

Prevalence of Malnutrition and Current Use of Nutrition Support in Patients With Cancer

(2014) Xavier Hébuterne et al.   JOURNAL OF PARENTERAL AND ENTERAL NUTRITION

Androgen-deprivation therapy alone or with docetaxel in non-castrate metastatic prostate cancer (GETUG-AFU 15): a randomised, open-label, phase 3 trial

(2013) Gwenaelle Gravis et al.   LANCET ONCOLOGY

Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics

(2012) Y Kanda   BONE MARROW TRANSPLANTATION

Understanding the mechanisms and treatment options in cancer cachexia

(2012) Kenneth Fearon et al.   Nature Reviews Clinical Oncology

Optimal management of cancer anorexia–cachexia syndrome

(2012) Jose Maria Argiles et al.   Cancer Management and Research

Oncological outcomes of the prostate cancer patients registered in 2004: Report from the Cancer Registration Committee of the JUA

(2011) Hiroyuki Fujimoto et al.   INTERNATIONAL JOURNAL OF UROLOGY

Pretreatment serum albumin as a predictor of cancer survival: A systematic review of the epidemiological literature

(2011) Digant Gupta et al.   Nutrition Journal

Lactate dehydrogenase, Gleason score and HER-2 overexpression are significant prognostic factors for M1b prostate cancer

(2011) Yamada   ONCOLOGY REPORTS

Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group

(2008) Howard I. Scher et al.   JOURNAL OF CLINICAL ONCOLOGY